| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.42 | 3e-35 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.42 | 3e-33 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.55 | 4e-31 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-29 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-27 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-24 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-23 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.33 | 7e-22 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.36 | 6e-21 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-18 |